ZAYED-SUSTAINABILITY
The Zayed Sustainability Prize, the UAE's pioneering global award for sustainability and humanitarianism, has officially closed entries for its 2025 awards cycle. A total of 5,980 applications were received across the six Prize categories of Health, Food, Energy, Water, Climate Action and Global High Schools, from 156 countries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240715270226/en/
Zayed Sustainability Prize Demonstrates Global Reach and Impact with over 5,900 Submissions (Graphic: AETOSWire)
The Zayed Sustainability Prize winners will be announced at the Awards Ceremony, which will be held on 14 January 2025 as part of Abu Dhabi Sustainability Week.
This year’s Prize has seen a notable 15% increase in submissions over the previous year from small and medium enterprises (SMEs), nonprofit organisations, and high schools. Close analysis of the submissions reveals a prevailing trend across all categories: a significant number of solutions are harnessing the power of artificial intelligence (AI), big data, blockchain, 3D printing, and biotechnology applications, revealing the importance of technological innovation in driving progress towards sustainability.
H.E. Dr. Sultan Ahmed Al Jaber, UAE Minister of Industry and Advanced Technology, Director General of the Zayed Sustainability Prize, and COP28 President, said: “For the last 16 years, the Zayed Sustainability Prize has supported innovative solutions that address pressing global challenges and deliver tangible impact to communities around the world. Inspired by Sheikh Zayed’s commitment to humanitarianism and people focused, inclusive sustainable development, the Prize has transformed the lives of over 384 million people.”
“We are deeply encouraged by the record number of applications we have received from every continent. This overwhelming response, particularly from young people and organisations in the Global South, reinforces our belief that innovations harnessing cutting-edge technologies like artificial intelligence, coupled with community-driven approaches, are key to effectively addressing climate change and driving social and environmental progress,” he added.
This year’s submissions were more varied than ever, highlighting the universal impact of climate change on nations across all continents. Most of the submissions came from emerging markets, revealing that rapidly developing countries are at the forefront of catalysing local, innovative solutions to address the sustainability gap.
The top submitting countries included Brazil, India, Kenya, Egypt, the United Arab Emirates and the United States. This year, the Prize accepted submissions in multiple languages, including Arabic, English, French, Mandarin, Portuguese, Russian and Spanish, promoting inclusivity, ensuring broader participation, and allowing diverse perspectives from different regions and cultures to be represented.
The Food (1,255) and Climate Action (1,532) categories attracted the greatest number of submissions, followed by Health (997), Global High Schools (906), Energy (669) and Water (621).
In the Food category, which received twice as many submissions compared to last year, the entries respond to challenges related to sustainable food production through innovations like agricultural technology (Agtech) for food system resilience.
Submissions addressing deforestation and rising carbon emissions dominated the Climate Action category, with organisations leading efforts in soil restoration, biodiversity enhancement, and sustainable resource use, fostering environmental sustainability.
SMEs and NPOs in the Health category predominantly focus on enhancing access to healthcare and disease prevention through solutions that leverage innovative technologies, community-driven programmes, and partnerships to bridge gaps in medical services, especially in underserved regions.
In the Energy category, the Prize received numerous entries from organisations dedicated to expanding sustainable energy access in vulnerable communities. While submissions featuring emerging technologies like hydrogen fuel systems, energy storage solutions and electric mobility, all critical for the global energy transition, also increased significantly.
Finally, in the Water category, many entries concentrate on enhancing water accessibility through innovative solutions that emphasise water conservation, advanced recycling techniques, filtration processes, and comprehensive treatment systems to ensure clean water resources for all.
The number of submissions from high schools has more than doubled compared to the previous year, signalling a significant increase in youth involvement and dedication to sustainable practices. In the Global High Schools category, the proposals included sustainable food production methods such as hydroponics and aquaponics, effective recycling and waste management strategies, the use of bioenergy, and the creation of bioproducts.
Following the close of submissions, the Prize now enters the evaluation stage. All entries will be shortlisted by an independent research and analysis consultancy. A Selection Committee comprised of globally renowned industry experts will then assess the qualified entries and shortlist the candidates. The third and final tier of the evaluation process is the Jury, which will convene in October to unanimously elect the winners in each category.
Since its launch in 2008, the US $5.9 million Prize has transformed the lives of over 384 million people around the world. Its global impact continues to grow, as it accelerates sustainable development and humanitarian progress. Each winner in the Health, Food, Energy, Water and Climate Action categories receive US $1 million to expand the scope and scale of their sustainability solution(s), while the Global High Schools category has six winners, representing six world regions, with each winner receiving up to US $150,000.
The Zayed Sustainability Prize is the UAE’s pioneering award for innovative solutions to global challenges.
A tribute to the legacy and vision of the UAE’s founding father, Sheikh Zayed bin Sultan Al Nahyan, the Prize aims to drive sustainable development worldwide.
Each year, across the Health, Food, Energy, Water, Climate Action and Global High Schools categories, the Prize rewards organisations and high schools for their groundbreaking solutions to our planet’s most pressing needs.
Through its 117 winners, in 16 years, the Prize has positively impacted over 384 million lives across the globe, inspiring innovators to amplify their impact, and chart a sustainable future for all.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715270226/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
